There are 2789 resources available
98P - A stable NGS method to detect microsatellite instability status across different batches, sequencing platforms and cancer types
Presenter: Chenghong Lin
Session: ePoster Display
99P - The differentially fragmented regions in cell-free DNA of colorectal cancer patients
Presenter: Dmitry Shcherbo
Session: ePoster Display
100P - Characteristics and outcomes of patients (pts) with NTRK fusion-positive (NTRK+) metastatic / locally advanced (LA) solid tumours receiving non-TRK inhibitor (TRKi) standard of care (SoC), and prognostic value of NTRK fusions in clinical practice
Presenter: George Demetri
Session: ePoster Display
101P - The landscape of MET alterations in European cancer patients
Presenter: Jürgen Wolf
Session: ePoster Display
102P - NTRK test usage practices in Europe and Asia: Findings from a real-world study
Presenter: Kriti Jindal
Session: ePoster Display
103P - Rate of BRCA1/2 pathogenic variants according to family and personal history of cancer in a large cohort of triple-negative breast cancer (TNBC) patients (pts) younger than 60 years of age
Presenter: Stefania Zovato
Session: ePoster Display
104P - Matching-adjusted indirect comparison for treatment of NTRK fusion cancer with larotrectinib versus entrectinib
Presenter: Jesus Garcia-Foncillas
Session: ePoster Display
210P - TACH101, a first-in-class KDM4 inhibitor for treatment of triple-negative breast cancer
Presenter: Frank Perabo
Session: ePoster Display
70P - A DNA methylation markers panel for prediction of luminal B breast cancer neoadjuvant chemotherapy response by quantitative PCR
Presenter: Aleksandra Nikolaeva
Session: ePoster Display
71P - Searching for predictive biomarkers of efficacy in small cell lung cancer (SCLC) patients treated with chemotherapy-immunotherapy combination using imaging mass cytometry (the HYPE study)
Presenter: Pierre Le Noac'h
Session: ePoster Display